- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07577076
Air Stacking-Assisted Diaphragmatic Breathing in Stroke
Effects of Diaphragmatic Breathing Exercise Using the Air Stacking Technique on Respiratory and Trunk Function in Patients With Stroke: A Randomized Controlled Trial
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
This clinical trial is a randomized controlled study designed to evaluate the effects of a diaphragmatic breathing exercise using the air stacking technique on respiratory and trunk function in patients with stroke. Patients with stroke are prone to respiratory muscle weakness, reduced chest wall expansion, and impaired trunk control, which can limit functional recovery and increase the risk of pulmonary complications. The air stacking technique increases lung volume and chest expansion through consecutive inspirations without exhalation and is known to facilitate more effective breathing and coughing, but its therapeutic effects in patients with stroke have not yet been fully established.
In this study, 20 patients with stroke will be randomly assigned to an experimental group (n = 10) or a control group (n = 10), using blocked randomization to ensure balance between groups. To enhance the objectivity of outcome assessment, all evaluations will be performed by an assessor who is blinded to group allocation. The experimental group will perform an air stacking-based diaphragmatic breathing exercise using an Ambu-bag, three times per week for 20 minutes over a 4-week period, in addition to neurodevelopmental treatment. The control group will receive therapist-guided diaphragmatic breathing exercises with the same frequency and duration, combined with the same neurodevelopmental treatment program. Both groups will receive the interventions for 4 weeks in the same rehabilitation setting.
All participants will undergo assessments before the start of the intervention and after completion of the 4-week program. Outcome measures will include pulmonary function tests (for example, FVC and FEV1), chest wall expansion, and trunk control ability. In addition, trunk function and functional mobility will be evaluated using the Korean version of the Trunk Impairment Scale (K-TIS) and the Five Times Sit-to-Stand Test (FTSTS), and perceived exertion during exercise will be assessed using the Borg Rating of Perceived Exertion (Borg RPE). Pre- to post-intervention changes will be calculated for each participant, and differences in these changes between the experimental and control groups will be analyzed.
The aim of this study is to determine whether a diaphragmatic breathing exercise using the air stacking technique provides additional benefits over conventional diaphragmatic breathing in improving pulmonary function, chest wall expansion, trunk control, and functional performance in patients with stroke. The findings are expected to demonstrate the therapeutic potential and clinical feasibility of an Ambu-bag-assisted air stacking technique and to contribute to the development of more effective respiratory and trunk rehabilitation strategies for individuals with stroke.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Daegu
-
Daegu, Daegu, Südkorea, 41199
- Daegu Fatima Hospital
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Inpatients diagnosed with stroke (intracerebral hemorrhage or cerebral infarction) at a general hospital in Daegu, currently receiving physical therapy
- Onset of stroke at least 3 months prior to enrollment
- Spasticity grade of 2 or less on the Modified Ashworth Scale
- No congenital deformity or fracture of the thorax or other orthopedic conditions affecting the chest wall
- No history of pulmonary disease before or after the stroke
- Able to perform respiratory exercises as instructed
- Mini-Mental State Examination-Korean version (MMSE-K) score of 24 or higher, indicating sufficient cognitive ability to understand the study procedures
- Presence of decreased pulmonary function (reduced pulmonary function test parameters) at baseline
Exclusion Criteria:
- Acute stroke status or onset of stroke less than 3 months prior to enrollment
- Severe cardiovascular or respiratory disease that makes participation in respiratory exercise unsafe or impossible
- Cognitive impairment or communication disorder that prevents understanding or performing the study procedures
- Any other medical or safety condition judged by the investigator to make participation in the study inappropriate
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Air stacking-assisted diaphragmatic breathing
articipants in this arm will receive diaphragmatic breathing exercises using the air stacking technique with an Ambu-bag three times per week for 20 minutes over 4 weeks, in addition to routine neurodevelopmental treatment.
|
Diaphragmatic breathing exercise using the air stacking technique with an Ambu-bag, performed three times per week for 20 minutes over 4 weeks, in addition to routine neurodevelopmental treatment.
|
|
Aktiver Komparator: diaphragmatic breathing
Participants in this arm will receive diaphragmatic breathing exercises three times per week for 20 minutes over 4 weeks, together with the same neurodevelopmental treatment as the experimental group.
|
diaphragmatic breathing exercise performed three times per week for 20 minutes over 4 weeks, together with the same neurodevelopmental treatment as the experimental group.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Forced Vital Capacity (FVC)
Zeitfenster: Baseline and 4 weeks after the start of intervention
|
Forced vital capacity (FVC) will be assessed using spirometry at baseline and 4 weeks after the start of the intervention.
The outcome measure is the change in FVC from baseline to 4 weeks in each group.
|
Baseline and 4 weeks after the start of intervention
|
|
Change in Forced Expiratory Volume in 1 Second (FEV1)
Zeitfenster: Baseline and 4 weeks after the start of intervention
|
Forced expiratory volume in 1 second (FEV1) will be assessed using spirometry at baseline and 4 weeks after the start of the intervention.
The outcome measure is the change in FEV1 from baseline to 4 weeks in each group.
|
Baseline and 4 weeks after the start of intervention
|
|
Change in FEV1/FVC ratio
Zeitfenster: Baseline and 4 weeks after the start of intervention
|
The ratio of forced expiratory volume in 1 second to forced vital capacity (FEV1/FVC) will be assessed using spirometry at baseline and 4 weeks after the start of the intervention.
The outcome measure is the change in FEV1/FVC from baseline to 4 weeks in each group.
|
Baseline and 4 weeks after the start of intervention
|
|
Change in Peak Expiratory Flow (PEF)
Zeitfenster: Baseline and 4 weeks after the start of intervention
|
Peak expiratory flow (PEF) will be assessed using spirometry at baseline and 4 weeks after the start of the intervention.
The outcome measure is the change in PEF from baseline to 4 weeks in each group.
|
Baseline and 4 weeks after the start of intervention
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Trunk Function (Korean Version of the Trunk Impairment Scale, K-TIS)
Zeitfenster: Baseline and 4 weeks after the start of intervention
|
Trunk function will be assessed using the Korean version of the Trunk Impairment Scale (K-TIS) at baseline and 4 weeks after the start of the intervention.
The K-TIS is a clinical scale ranging from 0 to 23, with higher scores indicating better trunk function.
The outcome measure is the change in K-TIS total score from baseline to 4 weeks in each group.
|
Baseline and 4 weeks after the start of intervention
|
|
Change in Functional Lower Extremity Performance (Five Times Sit-to-Stand Test, FTSTS)
Zeitfenster: Baseline and 4 weeks after the start of intervention
|
Functional lower extremity performance will be assessed using the Five Times Sit-to-Stand Test (FTSTS) at baseline and 4 weeks after the start of the intervention.
The FTSTS records the time in seconds required to complete five repetitions of rising from and returning to a seated position.
Higher times indicate poorer functional performance.
The outcome measure is the change in FTSTS completion time from baseline to 4 weeks in each group.
|
Baseline and 4 weeks after the start of intervention
|
|
Change in Perceived Exertion (Borg Rating of Perceived Exertion Scale)
Zeitfenster: Baseline and 4 weeks after the start of intervention
|
Perceived exertion during breathing exercises will be assessed using the Borg Rating of Perceived Exertion Scale at baseline and 4 weeks after the start of the intervention.
The Borg scale ranges from 6 to 20, with higher scores indicating greater perceived exertion.
The outcome measure is the change in Borg scale score from baseline to 4 weeks in each group.
|
Baseline and 4 weeks after the start of intervention
|
Mitarbeiter und Ermittler
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Neurologische Manifestationen
- Zerebrovaskuläre Erkrankungen
- Erkrankungen des Gehirns
- Erkrankungen des zentralen Nervensystems
- Erkrankungen des Nervensystems
- Gefäßerkrankungen
- Herz-Kreislauf-Erkrankungen
- Lähmung
- Pathologische Zustände, Anzeichen und Symptome
- Anzeichen und Symptome
- Streicheln
- Hemiplegie
Andere Studien-ID-Nummern
- 2025-05-001
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Air stacking-assisted diaphragmatic breathing
-
Hospital Nossa Senhora da ConceicaoRekrutierung
-
Universidade Cidade de Sao PauloFederal University of São PauloAbgeschlossen
-
Ullevaal University HospitalZurückgezogenRückenmarksverletzung | TetraplegieNorwegen
-
Fondazione Don Carlo Gnocchi OnlusAssociazione Italiana Glicogenosi (AIG); Associazione Riabilitatori Insufficienza... und andere MitarbeiterRekrutierungGlykogenspeicherkrankheit Typ II | Morbus Pompe (später Beginn)Italien
-
National Center of Neurology and Psychiatry, JapanRekrutierungAmyotrophe Lateralsklerose (ALS)Japan